D Turner

Summary

Affiliation: Shaare Zedek Medical Center
Country: Israel

Publications

  1. ncbi Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
    J Clin Epidemiol 62:374-9. 2009
  2. ncbi Appraisal of the pediatric ulcerative colitis activity index (PUCAI)
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
    Inflamm Bowel Dis 15:1218-23. 2009
  3. ncbi A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, POB 3235, Jerusalem 91031, Israel
    Clin Gastroenterol Hepatol 7:1081-8. 2009
  4. ncbi Assessing disease activity in ulcerative colitis: patients or their physicians?
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
    Inflamm Bowel Dis 16:651-6. 2010
  5. ncbi [Recommendations for the diagnosis and management of pediatric acute gastroenteritis in Israel]
    Dan Turner
    Pediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Israel
    Harefuah 149:53-8, 61, 60. 2010
  6. ncbi C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis
    Dan Turner
    Pediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel
    J Crohns Colitis 5:423-9. 2011
  7. ncbi Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis
    Dan Turner
    Shaare Zedek Medical Center, Jerusalem, Israel
    Inflamm Bowel Dis 16:469-73. 2010
  8. ncbi Pico-Salax versus polyethylene glycol for bowel cleanout before colonoscopy in children: a randomized controlled trial
    D Turner
    Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada
    Endoscopy 41:1038-45. 2009
  9. ncbi Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel
    Am J Gastroenterol 105:2085-92. 2010
  10. ncbi Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Israel
    Inflamm Bowel Dis 17:336-45. 2011

Detail Information

Publications32

  1. ncbi Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
    J Clin Epidemiol 62:374-9. 2009
    ..We compared the minimal important difference (MID) values obtained by the receiver operating characteristics (ROC) curve approach using different strategies on four outcome measures to guide the optimal use of ROC curve...
  2. ncbi Appraisal of the pediatric ulcerative colitis activity index (PUCAI)
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
    Inflamm Bowel Dis 15:1218-23. 2009
    ..We evaluated the psychometric performance of the Pediatric Ulcerative Colitis Activity Index (PUCAI) in a real-life cohort from the Pediatric IBD Collaborative Research Group...
  3. ncbi A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, POB 3235, Jerusalem 91031, Israel
    Clin Gastroenterol Hepatol 7:1081-8. 2009
    ..We performed a prospective study to systematically compare all non-invasive disease activity indices in patients with UC and to identify cutoff scores that correspond to remission and response...
  4. ncbi Assessing disease activity in ulcerative colitis: patients or their physicians?
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
    Inflamm Bowel Dis 16:651-6. 2010
    ..We aimed to determine the optimal approach to assess disease activity (i.e., biological inflammation) in ulcerative colitis (UC) by comparing patients' and physicians' rating of the disease...
  5. ncbi [Recommendations for the diagnosis and management of pediatric acute gastroenteritis in Israel]
    Dan Turner
    Pediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Israel
    Harefuah 149:53-8, 61, 60. 2010
    ..Nearly all children will experience at least one episode of acute gastroenteritis (AGE) by the age of three years. Acute gastroenteritis is a common cause of admissions to the pediatric wards in Israel, but usually the disease is mild...
  6. ncbi C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis
    Dan Turner
    Pediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel
    J Crohns Colitis 5:423-9. 2011
    ..There has not been an extensive comparison of CRP and ESR in ulcerative colitis (UC), and thus, we aimed to explore their utility in UC...
  7. ncbi Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis
    Dan Turner
    Shaare Zedek Medical Center, Jerusalem, Israel
    Inflamm Bowel Dis 16:469-73. 2010
    ..In this multicenter prospective study, we aimed to evaluate whether CS bioavailability plays a role in CS refractoriness in severe pediatric UC...
  8. ncbi Pico-Salax versus polyethylene glycol for bowel cleanout before colonoscopy in children: a randomized controlled trial
    D Turner
    Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada
    Endoscopy 41:1038-45. 2009
    ..Comparison of bowel preparation for colonoscopy in children with either Pico-Salax (sodium picosulphate with magnesium citrate) or polyethylene glycol with electrolyte solution (PEG-ELS)...
  9. ncbi Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel
    Am J Gastroenterol 105:2085-92. 2010
    ..The aim of this study was to provide knowledge on its performance and accuracy of different cutoff scores...
  10. ncbi Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Israel
    Inflamm Bowel Dis 17:336-45. 2011
    ..01-1.84) and symptoms of the upper gastrointestinal tract (RR 1.96; 95% CI: 1.37-2.80) in the n-3 treatment group. There are insufficient data to recommend the use of omega 3 fatty acids for maintenance of remission in CD and UC...
  11. ncbi Acute severe ulcerative colitis in children: a systematic review
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel
    Inflamm Bowel Dis 17:440-9. 2011
    ....
  12. ncbi Evidence-based recommendations for bowel cleansing before colonoscopy in children: a report from a national working group
    D Turner
    Pediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel
    Endoscopy 42:1063-70. 2010
    ..The Israeli Society of Pediatric Gastroenterology and Nutrition (ISPGAN) established an iterative working group to formulate evidence-based guidelines for bowel cleansing in children prior to colonoscopy...
  13. ncbi Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response
    D Turner
    Paediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, POB 3235, Jerusalem 91031, Israel
    Gut 59:1207-12. 2010
    ..To compare four faecal markers for their ability to predict steroid refractoriness in severe paediatric ulcerative colitis (UC). Construct validity and responsiveness to change were also assessed...
  14. ncbi Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN
    Dan Turner
    Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel
    Am J Gastroenterol 106:574-88. 2011
    ....
  15. ncbi Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Israel
    Inflamm Bowel Dis 18:55-62. 2012
    ....
  16. ncbi Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach
    Dan Turner
    Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada
    J Clin Epidemiol 62:738-44. 2009
    ..We aimed to compare the judgmental and mathematical approaches in weighting the Pediatric Ulcerative Colitis Activity Index (PUCAI)...
  17. ncbi Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy
    D Turner
    Division of Pediatric Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, 555 University Avenue, Toronto, M5G 1X8, Canada
    Gut 57:331-8. 2008
    ..We reviewed rates and predictors of response to intravenous-corticosteroid therapy in a single-centre cohort with long-term follow-up...
  18. ncbi Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study
    Dan Turner
    Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada
    Gastroenterology 133:423-32. 2007
    ..Colonoscopic appearance, the primary measure of disease activity in adult ulcerative colitis, is less acceptable to children. Our aim was to develop a noninvasive activity index of pediatric ulcerative colitis...
  19. ncbi The minimal detectable change cannot reliably replace the minimal important difference
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, Jerusalem 91031, Israel
    J Clin Epidemiol 63:28-36. 2010
    ..We compared the minimal important difference (MID) with the minimal detectable change (MDC) generated by distribution-based methods...
  20. ncbi Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics
    Eric I Benchimol
    Division of Gastroenterology, Hepatology and Nutrition, The Hospital of Sick Children, Toronto, Canada
    Am J Gastroenterol 103:1524-31. 2008
    ..This study assessed the clinical and radiologic characteristics of TMC in children with IBD...
  21. ncbi Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis
    T Gonska
    Department of Paediatrics, University of Toronto, Toronto, Canada
    Thorax 64:932-8. 2009
    ..A novel concept is proposed that may provide a more efficient real-time method for assessing CFTR function in vivo...
  22. ncbi Severe acute ulcerative colitis: the pediatric perspective
    Dan Turner
    Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem 91031, Israel
    Dig Dis 27:322-6. 2009
    ....
  23. ncbi Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression
    Dan Turner
    Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Canada
    Clin Gastroenterol Hepatol 5:103-10. 2007
    ..We aimed to systematically review studies that reported the short-term colectomy rate in severe UC or reported variables that could predict treatment failure...
  24. ncbi Protein-tyrosine phosphatase sigma is associated with ulcerative colitis
    Aleixo M Muise
    Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Toronto, 555 University Ave, Toronto, Ontario, Canada
    Curr Biol 17:1212-8. 2007
    ..We propose that polymorphisms in the human PTPRS gene lead to ulcerative colitis...
  25. ncbi Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response
    Dan Turner
    Shaare Zedek Medical Center, Jerusalem, Israel
    Gastroenterology 138:2282-91. 2010
    ..In a prospective study of children with severe ulcerative colitis (UC), we aimed to assess outcomes and to identify predictors of nonresponse to intravenous corticosteroids...
  26. ncbi Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis
    Dan Turner
    Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Hospital for Sick Children, 555 University Avenue, Toronto, M5G 1X8, Canada
    Curr Gastroenterol Rep 9:475-8. 2007
    ..Infliximab therapy for upper GI-CD seems as effective as that seen for more distal GI inflammation...
  27. ncbi Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children
    Juan Cristóbal Gana
    Division of Gastroenterology, Hepatology and Nutrition, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Israel
    J Pediatr Gastroenterol Nutr 50:188-93. 2010
    ..The objective of the study was to derive a noninvasive clinical prediction rule that is able to identify children with esophageal varices...
  28. ncbi Low levels of procalcitonin during episodes of necrotizing enterocolitis
    Dan Turner
    Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel
    Dig Dis Sci 52:2972-6. 2007
    ..1 ng/ml. We conclude that low procalcitonin values are the rule during episodes of NEC and provide further evidence that overactive local immune response, and not active infection, is primarily responsible for the mucosal damage in NEC...
  29. ncbi Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram
    D Turner
    Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel
    Arch Dis Child Fetal Neonatal Ed 91:F283-6. 2006
    ..To determine normal concentrations of procalcitonin in preterm infants shortly after birth and to assess its accuracy in detecting bacterial infection...
  30. ncbi The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants
    Dan Turner
    Departments of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel
    Acta Paediatr 95:1571-6. 2006
    ..To assess the role of procalcitonin in detecting nosocomial sepsis in preterm infants, after the onset of clinical symptoms...
  31. ncbi Hemolytic uremic syndrome after pediatric liver transplantation
    Dan Turner
    Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    J Pediatr Gastroenterol Nutr 43:109-12. 2006
  32. ncbi Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease
    Dan Turner
    Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada
    Am J Gastroenterol 102:2804-12; quiz 2803, 2813. 2007
    ..We report outcomes with methotrexate treatment in pediatric patients previously refractory to or intolerant of thiopurines...